The global surgical ablation market size was USD 6.14 Billion in 2022 and is expected to register a steady revenue CAGR of 6.8% during the forecast period, according to latest analysis by Emergen Research. Increasing prevalence of chronic disorders is a key factor driving market revenue growth. Surgical ablation is a type of procedure to remove or reprogram tissue in the body that is damaged or causing interference. According to the International Diabetes Federation's Diabetes Atlas, for 2021, around 537 million adults worldwide were diagnosed with diabetes in 2021, with the figure expected to rise to 643 million by 2030. Diabetes and strokes are common symptoms associated with cardiovascular disorders. Catheter ablation of Atrial Fibrillation (AF) appears to be a safe therapy that significantly reduces symptom load in people with Diabetic Mellitus (DM).